Shishir Shishodia to Fusion Proteins, bcr-abl
This is a "connection" page, showing publications Shishir Shishodia has written about Fusion Proteins, bcr-abl.
Connection Strength
0.113
-
Donato NJ, Wu JY, Stapley J, Lin H, Arlinghaus R, Aggarwal BB, Shishodia S, Albitar M, Hayes K, Kantarjian H, Talpaz M, Shishodin S. Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res. 2004 Jan 15; 64(2):672-7.
Score: 0.059
-
Mukhopadhyay A, Shishodia S, Suttles J, Brittingham K, Lamothe B, Nimmanapalli R, Bhalla KN, Aggarwal BB. Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors. J Biol Chem. 2002 Aug 23; 277(34):30622-8.
Score: 0.053